Xofluza, flu drug, snags new indication

November 24th 2020

FDA official says the approval is important because of the combination of the flu season and the COVID-19 pandemic.

FDA clears Regeneron's COVID-19 monoclonal antibody treatment and a home test

November 23rd 2020

Regeneron's investigational treatment was administered to President Donald Trump in October when he was treated for COVID-19.

Gottlieb optimistic about COVID-19 end after positive Moderna vaccine results

November 17th 2020

Blockbuster Keytruda earns new breast cancer indication

November 17th 2020

Merck earned a new indication for pembrolizumab (Keytruda), in combination with chemotherapy, to treat locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC).

FDA grants emergency use for COVID-19 treatment

November 10th 2020

The investigational monoclonal antibody therapy bamlanivimab treats mild-to-moderate COVID-19 in adult and pediatric patients.